02Oct 2019


Crossref Cited-by Linking logo
  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Background: Many surgical procedures have been proposed for management of morbid obesity. This study was conducted aiming to compare between the outcomes of open loop duodenal switch (DS) and laparoscopic minigastric bypass (MGB) procedures. Study type: Prospective comparative study. Patient and methods: 50 patients were included in the study. They were divided into 2 groups; group 1 included 25 patients who underwent open loop DS while group 2 included 25 patients who underwent laparoscopic minigastric bypass. All patients were subjected to complete history taking, physical examination, and routine investigations. Lipid profile and diabetic status were also assessed. After discharge, patients were followed up at 3, 6, and 12 months after the procedures where weight, BMI, and laboratory investigations were assessed in each visit. Results: The mean age of the included patients was 34.76 for the DS group and 36.0 years for MGB group. In each group, 20 females (80%) as well as 5 males (20%) were included. The mean BMI of the included patients was 52.59 and 51.6 kg/m2 for both groups respectively. No significant difference was detected between the two groups regarding preoperative albumin, lipid profile, or HbA1c levels. Mean patient weight decreased postoperatively to 128.92, 117.63, and 105.28 kg after 3, 6, and 12 months in DS group. In the MGB group, mean weight decreased to 133.75, 124.14, 117.16 kg at the same time intervals respectively. BMI decreased to 48.45, 43.01, and 38.27 kg/m2 in DS group while in the other group it showed a decrease down to 49.35, 46.89, and 42.33 kg/m2 at the previously reported time intervals in order of speech. It was evident that 6- and 12-month changes were significantly better in Ds group compared to MGB group (p < 0.05). Conclusion: Based on the results of the current study, it was evident that both open loop duodenal switch and laparoscopic minigastric bypass procedures are effective in the management of morbid obesity and its related comorbidities. However, loop DS operation is more effective in weight loss compared to MGB.

  1. Prachand V.N., DaVee R.T., and Alverdy J.C. Duodenal switch provides superior weight loss in the super-obese (BMI≥ 50kg/m2) compared with gastric bypass. Annals of surgery 2006, 244 (4), 611.
  2. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. Jama 2006, 295 (13), 1549-1555.
  3. Sturm R. Increases in morbid obesity in the USA: 2000?2005. Public health 2007, 121 (7), 492-496.
  4. Williams E.P., Mesidor M., Winters K., Dubbert P.M., and Wyatt S.B. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Current obesity reports 2015, 4 (3), 363-370.
  5. DeMaria E.J., Pate V., Warthen M., and Winegar D.A. Baseline data from American society for metabolic and bariatric surgery-designated bariatric surgery centers of excellence using the bariatric outcomes longitudinal database. Surgery for Obesity and Related Diseases 2010, 6 (4), 347-355.
  6. Jammu G.S. and Sharma R. A 7-year clinical audit of 1107 patients comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obesity surgery 2016, 26 (5), 926-932.
  7. Scopinaro N., Gianetta E., Civalleri D., Bonalumi U., and Bachi V. Bilio‐pancreatic bypass for obesity: II. Initial experience in man. British Journal of Surgery 1979, 66 (9), 618-620.
  8. Rubino F. and Marescaux J. Effect of duodenal?jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Annals of surgery 2004, 239 (1), 1.
  9. S?nchez-Pernaute A., Herrera M.A.R., P?rez-Aguirre M.E., Talavera P., Cabrerizo L., Mat?a P., D?ez-Valladares L., Barabash A., Mart?n-Antona E., and Garc?a-Botella A. Single anastomosis duodeno?ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obesity surgery 2010, 20 (12), 1720-1726.
  10. Marceau P., Biron S., Bourque R.-A., Potvin M., Hould F.-S., and Simard S. Biliopancreatic diversion with a new type of gastrectomy. Obesity surgery 1993, 3 (1), 29-35.
  11. Padwal R., Klarenbach S., Wiebe N., Birch D., Karmali S., Manns B., Hazel M., Sharma A., and Tonelli M. Bariatric surgery: a systematic review and network meta‐analysis of randomized trials. Obesity Reviews 2011, 12 (8), 602-621.
  12. Weiner J.P., Goodwin S.M., Chang H.-Y., Bolen S.D., Richards T.M., Johns R.A., Momin S.R., and Clark J.M. Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data. JAMA surgery 2013, 148 (6), 555-561.
  13. Mahawar K.K., Jennings N., Brown J., Gupta A., Balupuri S., and Small P.K. ?Mini? gastric bypass: systematic review of a controversial procedure. Obesity surgery 2013, 23 (11), 1890-1898.
  14. Noun R., Skaff J., Riachi E., Daher R., Antoun N.A., and Nasr M. One thousand consecutive mini-gastric bypass: short-and long-term outcome. Obesity surgery 2012, 22 (5), 697-703.
  15. Rutledge R., Kular K., Marchanda N., Bandari M., and Goel R. A comparison of the outcomes of revision of the Roux-en-Y (RNY) and mini-gastric bypass (MGB); hard vs. easy. Eur J Endosc Laparosc Surg 2014, 1, 1-6.
  16. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., and Schoelles K. Bariatric surgery: a systematic review and meta-analysis. Jama 2004, 292 (14), 1724-1737.
  17. Afaneh C. and Pomp A.; Duodenal Switch: Technique and Outcomes, in The SAGES Manual of Bariatric Surgery 2018, Springer. p. 327-338.
  18. Abd-Elatif A., Youssef T., Farid M., Ali Y., and Gado W. Nutritional markers after loop duodenal switch (SADI-S) for morbid obesity: a technique with favorable nutritional outcome. J Obes Weight Loss Ther 2015, 5 (3), 1000268.
  19. Musella M., Susa A., Manno E., De Luca M., Greco F., Raffaelli M., Cristiano S., Milone M., Bianco P., and Vilardi A. Complications following the mini/one anastomosis gastric bypass (MGB/OAGB): a multi-institutional survey on 2678 patients with a mid-term (5 years) follow-up. Obesity surgery 2017, 27 (11), 2956-2967.
  20. S?nchez-Pernaute A., Rubio M.?., Cabrerizo L., Ramos-Levi A., P?rez-Aguirre E., and Torres A. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients. Surgery for Obesity and Related Diseases 2015, 11 (5), 1092-1098.
  21. Cottam A., Cottam D., Medlin W., Richards C., Cottam S., Zaveri H., and Surve A. A matched cohort analysis of single anastomosis loop duodenal switch versus Roux-en-Y gastric bypass with 18-month follow-up. Surgical endoscopy 2016, 30 (9), 3958-3964.
  22. Deitel M. and Kular K.S. Consensus survey on mini-gastric bypass and one-anastomosis gastric bypass. Ann Bariatr Metab Surg 2018, 1, 1001.
  23. Moon R.C., Gaskins L., Teixeira A.F., and Jawad M.A. Safety and effectiveness of single-anastomosis duodenal switch procedure: 2-year result from a single US institution. Obesity surgery 2018, 28 (6), 1571-1577.
  24. Magouliotis D., Tasiopoulou V., and Tzovaras G. One anastomosis gastric bypass versus Roux‐en‐Y gastric bypass for morbid obesity: a meta‐ Clinical obesity 2018, 8 (3), 159-169.
  25. Bhandari M., Nautiyal H.K., Kosta S., Mathur W., and Fobi M. Comparison of One anastomosis gastric bypass (OAGB) and Roux-en-Y gastric bypass (RYGB) for Treatment of Obesity: A Five-Year Study. Surgery for Obesity and Related Diseases 2019.
  26. Robert M., Espalieu P., Pelascini E., Caiazzo R., Sterkers A., Khamphommala L., Poghosyan T., Chevallier J.-M., Malherbe V., and Chouillard E. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. The Lancet 2019, 393 (10178), 1299-1309.
  27. Dijkhorst P.J., Boerboom A.B., Janssen I.M., Swank D.J., Wiezer R.M., Hazebroek E.J., Berends F.J., and Aarts E.O. Failed sleeve gastrectomy: single anastomosis duodenoileal bypass or Roux-en-Y gastric bypass? A multicenter cohort study. Obesity surgery 2018, 28 (12), 3834-3842.
  28. Carbajo M.A., Luque-de-Le?n E., Jim?nez J.M., Ortiz-de-Sol?rzano J., P?rez-Miranda M., and Castro-Alija M.J. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obesity surgery 2017, 27 (5), 1153-1167.
  29. Kular K., Manchanda N., and Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses?first study from Indian subcontinent. Obesity surgery 2014, 24 (9), 1430-1435.
  30. Cottam A., Cottam D., Roslin M., Cottam S., Medlin W., Richards C., Surve A., and Zaveri H. A matched cohort analysis of sleeve gastrectomy with and without 300 cm loop duodenal switch with 18-month follow-up. Obesity surgery 2016, 26 (10), 2363-2369.
  31. Chevallier J.-M.; Effects of MGB on Obesity-Related Co-Morbidities: Lipids, Hypertension, Non-Alcoholic Fatty Liver, etc, in Essentials of Mini‒One Anastomosis Gastric Bypass 2018, Springer. p. 111-117.
  32. Mingrone G., Panunzi S., De Gaetano A., Guidone C., Iaconelli A., Leccesi L., Nanni G., Pomp A., Castagneto M., and Ghirlanda G. Bariatric surgery versus conventional medical therapy for type 2 diabetes. New England Journal of Medicine 2012, 366 (17), 1577-1585.
  33. Iaconelli A., Panunzi S., De Gaetano A., Manco M., Guidone C., Leccesi L., Gniuli D., Nanni G., Castagneto M., and Ghirlanda G. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes care 2011, 34 (3), 561-567.
  34. Tsoli M., Chronaiou A., Kehagias I., Kalfarentzos F., and Alexandrides T.K. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surgery for Obesity and Related Diseases 2013, 9 (5), 667-677.
  35. Buchwald H., Estok R., Fahrbach K., Banel D., Jensen M.D., Pories W.J., Bantle J.P., and Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. The American journal of medicine 2009, 122 (3), 248-256. e5.
  36. Astiarraga B., Gastaldelli A., Muscelli E., Baldi S., Camastra S., Mari A., Papadia F., Camerini G., Adami G., and Scopinaro N. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. The Journal of Clinical Endocrinology & Metabolism 2013, 98 (7), 2765-2773.
  37. Deitel M., Hargroder D., and Peraglie C. Mini-gastric bypass for bariatric surgery increasing worldwide. Austin J Surg 2016, 3 (3), 1092-1096.
  38. Luciani R.C.; The MGB-OAGB International Club?, in Essentials of Mini‒One Anastomosis Gastric Bypass 2018, Springer. p. 355-360.
  39. Forieg A.M.; Effects of MGB on Type 2 Diabetes in Morbid Obesity, and Comparison with Other Operations, in Essentials of Mini‒One Anastomosis Gastric Bypass 2018, Springer. p. 119-130.
  40. Jammu G.S. and Sharma R. An eight-year experience with 189 Type 2 diabetic patients after mini-gastric bypass. Integr Obes Diabetes 2016, 2 (4), 246-249.
  41. Kim M.J., Park H.K., Byun D.W., Suh K.I., and Hur K.Y. Incretin levels 1 month after laparoscopic single anastomosis gastric bypass surgery in non-morbid obese type 2 diabetes patients. Asian journal of surgery 2014, 37 (3), 130-137.
  42. Lee W.-J., Chong K., Lin Y.-H., Wei J.-H., and Chen S.-C. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obesity surgery 2014, 24 (9), 1552-1562.
  43. Prachand V.N. and Hussain M.; Duodenal Switch: Technique and Outcomes, in The ASMBS Textbook of Bariatric Surgery 2015, Springer. p. 211-220.

[Yasser Ali Elsayed, Atif Mohamed Abd El -Latif, Tamer Youssef Mohamed, Hesham Mohamed Abdalla and Mohamed khidr Mohamed. (2019); COMPARATIVE STUDY BETWEEN SLEEVE GASTRECTOMY WITH SINGLE ANASTOMOSIS DUODENO-ILEAL BYPASS AND MINI-GASTRIC BYPASS IN MANAGEMENT OF MORBID OBESITY. Int. J. of Adv. Res. 7 (10). 72-83] (ISSN 2320-5407). www.journalijar.com

Mohamed Khidr Mohamed
mansoura medical school


Article DOI: 10.21474/IJAR01/9808       DOI URL: http://dx.doi.org/10.21474/IJAR01/9808

Share this article